Drug Trial Radar · NCT07766655
Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)
Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
705
Planned (sponsor's estimate)
Start
Aug 27, 2026
Primary completion
Dec 2027
Study completion Dec 2027
Sponsor
- Lead sponsor
- Axsome Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 14, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a Phase 3, multicenter, randomized, double-blind, placebo- and active-controlled, parallel-group trial to evaluate the efficacy and safety of AXS-05 compared to placebo and bupropion for smoking cessation in adults.
Conditions
- Smoking Cessation
Interventions
AXS-05 (dextromethorphan-bupropion)Drug
AXS-05 tablets, taken twice daily for 12 weeks.
BupropionDrug
Bupropion tablets, taken twice daily for 12 weeks.
PlaceboDrug
Placebo tablets, taken twice daily for 12 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- 4-Week Continuous Smoking Abstinence RateTime frame: Weeks 9 to 12
Locations
28 sites in 1 country. Site status is shown where the registry gives one.
Clinical Research Site
Phoenix, Arizona · Recruiting
Clinical Research Site
Little Rock, Arkansas · Recruiting
Clinical Research Site
Lemon Grove, California · Recruiting
Clinical Research Site
Long Beach, California · Recruiting
Clinical Research Site
Pomona, California · Recruiting
Clinical Research Site
DeLand, Florida · Recruiting
Clinical Research Site
Jacksonville, Florida · Recruiting
Clinical Research Site
Orlando, Florida · Recruiting
Clinical Research Site
Tampa, Florida · Recruiting
Clinical Research Site
Columbus, Georgia · Recruiting
Clinical Research Site
Stockbridge, Georgia · Recruiting
Clinical Research Site
Skokie, Illinois · Recruiting
Clinical Research Site
Evansville, Indiana · Recruiting
Clinical Research Site
Kansas City, Missouri · Recruiting
Clinical Research Site
Brooklyn, New York · Recruiting
Clinical Research Site
Brooklyn, New York · Recruiting
Clinical Research Site
Rochester, New York · Recruiting
Clinical Research Site
Mount Airy, North Carolina · Recruiting
Clinical Research Site
Duncansville, Pennsylvania · Recruiting
Clinical Research Site
North Charleston, South Carolina · Recruiting
Clinical Research Site
Knoxville, Tennessee · Recruiting
Clinical Research Site
Memphis, Tennessee · Recruiting
Clinical Research Site
Nashville, Tennessee · Recruiting
Clinical Research Site
Austin, Texas · Recruiting
Clinical Research Site
Dallas, Texas · Recruiting
Clinical Research Site
Fort Worth, Texas · Recruiting
Clinical Research Site
Huston, Texas · Recruiting
Clinical Research Site
Newport News, Virginia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.